StockDriftsStockDriftsTop 26 Chi Advisors Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS INC | 20.74% | 3.15M | $52.3M | -2.94%(-95.62K) | — | 2023-09-30 | |
| RPTX | REPARE THERAPEUTICS INC | 14.27% | 3.02M | $36.0M | +0.60%(+17.94K) | — | 2023-09-30 | |
| CGEM | CULLINAN ONCOLOGY INC | 12.25% | 3.41M | $30.9M | +0.00%(+0) | — | 2023-09-30 | |
| SLRN | ACELYRIN INC | 9.12% | 2.26M | $23.0M | -15.05%(-400.82K) | — | 2023-09-30 | |
| ORTX | ORCHARD THERAPEUTICS PLC | 5.56% | 12.32M | $14.0M | +1529.62%(+11.56M) | — | 2023-09-30 | |
| LRMR | LARIMAR THERAPEUTICS INC | 5.35% | 3.41M | $13.5M | +0.00%(+0) | — | 2023-09-30 | |
| KROS | KEROS THERAPEUTICS INC | 5.15% | 407.6K | $13.0M | +1.37%(+5.51K) | — | 2023-09-30 | |
| IKNA | IKENA ONCOLOGY INC | 3.74% | 2.18M | $9.4M | +2.78%(+58.89K) | — | 2023-09-30 | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 3.04% | 215.0K | $7.7M | +152.94%(+130.00K) | — | 2023-09-30 | |
| CMPX | COMPASS THERAPEUTICS INC | 2.21% | 2.83M | $5.6M | +0.00%(+0) | — | 2023-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Chi Advisors Llc reports $252.31M in US-listed equity holdings across 28 positions in its most recent 13F filing. Its largest disclosed positions are PLRX (20.7%), RPTX (14.3%) and CGEM (12.3%). Figures reflect the Q3 2023 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Chi Advisors Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Chi Advisors Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1791468). View Chi Advisors Llc’s 13F filings on SEC